» Articles » PMID: 39384770

The Multiple Roles of Interferon Regulatory Factor Family in Health and Disease

Overview
Date 2024 Oct 9
PMID 39384770
Authors
Affiliations
Soon will be listed here.
Abstract

Interferon Regulatory Factors (IRFs), a family of transcription factors, profoundly influence the immune system, impacting both physiological and pathological processes. This review explores the diverse functions of nine mammalian IRF members, each featuring conserved domains essential for interactions with other transcription factors and cofactors. These interactions allow IRFs to modulate a broad spectrum of physiological processes, encompassing host defense, immune response, and cell development. Conversely, their pivotal role in immune regulation implicates them in the pathophysiology of various diseases, such as infectious diseases, autoimmune disorders, metabolic diseases, and cancers. In this context, IRFs display a dichotomous nature, functioning as both tumor suppressors and promoters, contingent upon the specific disease milieu. Post-translational modifications of IRFs, including phosphorylation and ubiquitination, play a crucial role in modulating their function, stability, and activation. As prospective biomarkers and therapeutic targets, IRFs present promising opportunities for disease intervention. Further research is needed to elucidate the precise mechanisms governing IRF regulation, potentially pioneering innovative therapeutic strategies, particularly in cancer treatment, where the equilibrium of IRF activities is of paramount importance.

Citing Articles

Genetic diversity of the immunoglobulin heavy chain locus in cohorts of patients affected with SARS-CoV-2.

Malaspina P, Jodice C, Ciminelli B, Biancolella M, Colona V, Latini A Hum Genomics. 2025; 19(1):7.

PMID: 39885568 PMC: 11780896. DOI: 10.1186/s40246-025-00719-8.


Interplay of Transcriptomic Regulation, Microbiota, and Signaling Pathways in Lung and Gut Inflammation-Induced Tumorigenesis.

Otalora-Otalora B, Payan-Gomez C, Lopez-Rivera J, Pedroza-Aconcha N, Arboleda-Mojica S, Aristizabal-Guzman C Cells. 2025; 14(1.

PMID: 39791702 PMC: 11720097. DOI: 10.3390/cells14010001.


Network-based transfer of pan-cancer immunotherapy responses to guide breast cancer prognosis.

Ding X, Zhang L, Fan M, Li L NPJ Syst Biol Appl. 2025; 11(1):4.

PMID: 39788975 PMC: 11720706. DOI: 10.1038/s41540-024-00486-7.

References
1.
Ma X, Geng K, Law B, Wang P, Pu Y, Chen Q . Lipotoxicity-induced mtDNA release promotes diabetic cardiomyopathy by activating the cGAS-STING pathway in obesity-related diabetes. Cell Biol Toxicol. 2022; 39(1):277-299. PMC: 10042943. DOI: 10.1007/s10565-021-09692-z. View

2.
Deveci Ozkan A, Kaleli S, Onen H, Sarihan M, Eskiler G, Kalayci Yigin A . Anti-inflammatory effects of nobiletin on TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways in prostate cancer cells. Immunopharmacol Immunotoxicol. 2020; 42(2):93-100. DOI: 10.1080/08923973.2020.1725040. View

3.
Testa U, Stellacci E, Pelosi E, Sestili P, Venditti M, Orsatti R . Impaired myelopoiesis in mice devoid of interferon regulatory factor 1. Leukemia. 2004; 18(11):1864-71. DOI: 10.1038/sj.leu.2403472. View

4.
Jefferies C . Regulating IRFs in IFN Driven Disease. Front Immunol. 2019; 10:325. PMC: 6449421. DOI: 10.3389/fimmu.2019.00325. View

5.
Guo M, Yan R, Ji Q, Yao H, Sun M, Duan L . IFN regulatory Factor-1 induced macrophage pyroptosis by modulating m6A modification of circ_0029589 in patients with acute coronary syndrome. Int Immunopharmacol. 2020; 86:106800. DOI: 10.1016/j.intimp.2020.106800. View